Press ReleaseNicox Granted New Patent for NCX 4251 in Japan Newly granted patent extends the coverage for NCX 4251 in Japan to 2040Complements the recent.
Press ReleaseNicox's Positive FDA Meeting Shows Clear Path for NCX 4251 in Dry Eye Statistically significant and clinically relevant results were obtained for the reduction of dry eye symptoms in
Press ReleaseNicox European Patent Seals ZERVIATE Major Market Coverage to 2030 Patent coverage for ZERVIATE (cetirizine ophthalmic solution), 0.24% in Europe until 2030 January 5, 2022 - release